These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7527739)

  • 1. Antigenic structure of the hepatitis C virus envelope 2 protein.
    Zhang ZX; Sönnerborg A; Sällberg M
    Clin Exp Immunol; 1994 Dec; 98(3):382-7. PubMed ID: 7527739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic regions within the hepatitis C virus envelope 1 and non-structural proteins: identification of an IgG3-restricted recognition site with the envelope 1 protein.
    Sällberg M; Rudén U; Wahren B; Magnius LO
    Clin Exp Immunol; 1993 Mar; 91(3):489-94. PubMed ID: 7680297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic structure of the complete nonstructural (NS) 2 and 5 proteins of hepatitis C virus (HCV): anti-HCV NS2 and NS5 antibody reactivities in relation to HCV serotype, presence of HCV RNA, and acute HCV infection.
    Zhang ZX; Chen M; Sönnerborg A; Sällberg M
    Clin Diagn Lab Immunol; 1994 May; 1(3):290-4. PubMed ID: 7496964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal Antibodies Directed toward the Hepatitis C Virus Glycoprotein E2 Detect Antigenic Differences Modulated by the N-Terminal Hypervariable Region 1 (HVR1), HVR2, and Intergenotypic Variable Region.
    Alhammad Y; Gu J; Boo I; Harrison D; McCaffrey K; Vietheer PT; Edwards S; Quinn C; Coulibaly F; Poumbourios P; Drummer HE
    J Virol; 2015 Dec; 89(24):12245-61. PubMed ID: 26378182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locations of antibody binding sites within conserved regions of the hepatitis C virus core protein.
    Sällberg M; Pumpen P; Zhang ZX; Lundholm P; Gusars I; Rudén U; Wahren B; Magnius LO
    J Med Virol; 1994 May; 43(1):62-8. PubMed ID: 7521899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCV core immunodominant region analysis using mouse monoclonal antibodies and human sera: characterization of major epitopes useful for antigen detection.
    Jolivet-Reynaud C; Dalbon P; Viola F; Yvon S; Paranhos-Baccala G; Piga N; Bridon L; Trabaud MA; Battail N; Sibai G; Jolivet M
    J Med Virol; 1998 Dec; 56(4):300-9. PubMed ID: 9829633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and mapping of a B-cell immunogenic domain in hepatitis C virus E2 glycoprotein using a yeast peptide library.
    Mink MA; Benichou S; Madaule P; Tiollais P; Prince AM; Inchauspe G
    Virology; 1994 Apr; 200(1):246-55. PubMed ID: 7510436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypervariable 5'-terminus of hepatitis C virus E2/NS1 encodes antigenically distinct variants.
    Lesniewski RR; Boardway KM; Casey JM; Desai SM; Devare SG; Leung TK; Mushahwar IK
    J Med Virol; 1993 Jun; 40(2):150-6. PubMed ID: 7689636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic and immunogenic evaluation of permutations of soluble hepatitis C virus envelope protein E2 and E1 antigens.
    Prentoe J; Janitzek CM; Velázquez-Moctezuma R; Goksøyr L; Olsen RW; Fanalista M; Augestad EH; Thrane S; Pihl AF; Gottwein JM; Sander AF; Bukh J
    PLoS One; 2021; 16(7):e0255336. PubMed ID: 34329365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells.
    Rosa D; Campagnoli S; Moretto C; Guenzi E; Cousens L; Chin M; Dong C; Weiner AJ; Lau JY; Choo QL; Chien D; Pileri P; Houghton M; Abrignani S
    Proc Natl Acad Sci U S A; 1996 Mar; 93(5):1759-63. PubMed ID: 8700831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunodominant B-cell domains of hepatitis C virus envelope proteins E1 and E2 identified during early and late time points of infection.
    Zibert A; Kraas W; Ross RS; Meisel H; Lechner S; Jung G; Roggendorf M
    J Hepatol; 1999 Feb; 30(2):177-84. PubMed ID: 10068093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays.
    Ali A; Nisar M; Idrees M; Rafique S; Iqbal M
    Int J Infect Dis; 2015 May; 34():84-9. PubMed ID: 25796431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3.
    Simmonds P; Rose KA; Graham S; Chan SW; McOmish F; Dow BC; Follett EA; Yap PL; Marsden H
    J Clin Microbiol; 1993 Jun; 31(6):1493-503. PubMed ID: 7686182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections.
    Weiner AJ; Geysen HM; Christopherson C; Hall JE; Mason TJ; Saracco G; Bonino F; Crawford K; Marion CD; Crawford KA
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3468-72. PubMed ID: 1314389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis for antibody cross-reactivity between the hepatitis C virus core protein and the host-derived GOR protein.
    Zhang ZX; Chen M; Wallhagen K; Trojnar J; Magnius LO; Wahren B; Sällberg M
    Clin Exp Immunol; 1994 Jun; 96(3):403-9. PubMed ID: 7516270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping and characterization of B cell linear epitopes in the conservative regions of hepatitis C virus envelope glycoproteins.
    Olenina LV; Nikolaeva LI; Sobolev BN; Blokhina NP; Archakov AI; Kolesanova EF
    J Viral Hepat; 2002 May; 9(3):174-82. PubMed ID: 12010504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of neutralizing monoclonal antibodies against Hepatitis C virus E2 protein effectively blocks virus infection.
    Bose M; Mullick R; Das S; Das S; Karande AA
    Virus Res; 2016 Sep; 224():46-57. PubMed ID: 27574733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of a conformational epitope shared between E1 and E2 on the serum-derived human hepatitis C virus envelope.
    Petit MA; Jolivet-Reynaud C; Peronnet E; Michal Y; Trépo C
    J Biol Chem; 2003 Nov; 278(45):44385-92. PubMed ID: 12882983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody responses to the hepatitis C virus E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects.
    Cerino A; Bissolati M; Cividini A; Nicosia A; Esumi M; Hayashi N; Mizuno K; Slobbe R; Oudshoorn P; Silini E; Asti M; Mondelli MU
    J Med Virol; 1997 Jan; 51(1):1-5. PubMed ID: 8986942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic mimicking with cysteine-based cyclized peptides reveals a previously unknown antigenic determinant on E2 glycoprotein of classical swine fever virus.
    Chang CY; Huang CC; Deng MC; Huang YL; Lin YJ; Liu HM; Lin YL; Wang FI
    Virus Res; 2012 Jan; 163(1):190-6. PubMed ID: 21945636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.